THE BISPHOSPHONATE ZOLEDRONIC ACID DECREASES TUMOR GROWTH IN BONE IN MICE WITH DEFECTIVE OSTEOCLASTS

Bisphosphonates (BPs), bone targeted drugs that disrupt osteoclast function, are routinely used to treat complications of bone metastasis. Studies in preclinical models of cancer have shown that BPs reduce skeletal tumor burden and increase survival. Similarly, we observed in the present study that...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Hirbe, Angela C., Roelofs, Anke J., Floyd, Desiree H., Deng, Hongju, Becker, Stephanie N., Lanigan, Lisa G., Apicelli, Anthony J., Xu, Zhiqiang, Prior, Julie L., Eagleton, Mark C., Piwnica-Worms, David, Rogers, Michael J., Weilbaecher, Katherine
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2009
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC2782613/
https://ncbi.nlm.nih.gov/pubmed/19442620
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bone.2009.01.010
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia